These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30647096)

  • 1. Young adult with Friedreich ataxia.
    Milano EG; Harries IB; Bucciarelli-Ducci C
    Heart; 2019 May; 105(10):797-806. PubMed ID: 30647096
    [No Abstract]   [Full Text] [Related]  

  • 2. Peak Filling Rates Assessed by CMR Imaging Indicate Diastolic Dysfunction From Myocardial Iron Toxicity.
    Schoennagel BP; Fischer R; Grosse R; Berliner C; Wehbe M; Kurio G; Lund G; Wang ZJ; Graessner J; Adam G; Yamamura J
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1353-1354. PubMed ID: 26777217
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of myocardial iron overload by two-dimensional speckle tracking in patients with beta-thalassaemia major: a combined echocardiographic and T2* segmental CMR study.
    Pizzino F; Meloni A; Terrizzi A; Casini T; Spasiano A; Cosmi C; Allò M; Zito C; Carerj S; Aquaro GD; Di Bella G; Pepe A
    Int J Cardiovasc Imaging; 2018 Feb; 34(2):263-271. PubMed ID: 28770456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum versus Imaging Biomarkers in Friedreich Ataxia to Indicate Left Ventricular Remodeling and Outcomes.
    Mehta N; Chacko P; Jin J; Tran T; Prior TW; He X; Agarwal G; Raman SV
    Tex Heart Inst J; 2016 Aug; 43(4):305-10. PubMed ID: 27547137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome.
    Raman SV; Phatak K; Hoyle JC; Pennell ML; McCarthy B; Tran T; Prior TW; Olesik JW; Lutton A; Rankin C; Kissel JT; Al-Dahhak R
    Eur Heart J; 2011 Mar; 32(5):561-7. PubMed ID: 21156720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of cytosolic iron excess to cardiomyopathy of Friedreich's ataxia.
    Ramirez RL; Qian J; Santambrogio P; Levi S; Koeppen AH
    Am J Cardiol; 2012 Dec; 110(12):1820-7. PubMed ID: 23000103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyopathy of Friedreich ataxia.
    Weidemann F; Störk S; Liu D; Hu K; Herrmann S; Ertl G; Niemann M
    J Neurochem; 2013 Aug; 126 Suppl 1():88-93. PubMed ID: 23859344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Iron Deposition Is Directly Associated With Myocardial Dysfunction in Patients With Sickle Cell Disease.
    Fujikura K; Golive AD; Ando T; Corado FM; Shitole SG; Kizer JR; Shah AM; Prince MR; Spevack DM; Garcia MJ
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):279-280. PubMed ID: 28412428
    [No Abstract]   [Full Text] [Related]  

  • 9. The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases.
    Lamarche JB; Côté M; Lemieux B
    Can J Neurol Sci; 1980 Nov; 7(4):389-96. PubMed ID: 6452194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Syrian golden hamster: a model for the cardiomyopathy of Friedreich's ataxia.
    Azari J; Reisine T; Barbeau A; Yamamura HI; Huxtable R
    Can J Neurol Sci; 1979 May; 6(2):223-6. PubMed ID: 226257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?
    Wijarnpreecha K; Kumfu S; Chattipakorn SC; Chattipakorn N
    Hemoglobin; 2015; 39(1):9-17. PubMed ID: 25572185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial.
    Shakoor A; Zahoor M; Sadaf A; Alvi N; Fadoo Z; Rizvi A; Quadri F; Tipoo FA; Khurshid M; Sajjad Z; Colan S; Hasan BS
    BMJ Open; 2014 Dec; 4(12):e005360. PubMed ID: 25492271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wernicke's encephalopathy and cardiomyopathy in a boy with Friedreich's ataxia.
    Exss R; Gullotta F; Kallfelz HC; Völpel M
    Neuropadiatrie; 1974 May; 5(2):162-74. PubMed ID: 4407855
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac dysfunction exacerbated by endocrinopathies in Friedreich ataxia: a case series.
    Snyder M; Seyer L; Lynch DR; Resnick A; Zesiewicz TA
    J Child Neurol; 2012 Oct; 27(10):1316-9. PubMed ID: 22408141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autopsy case of secondary iron-overload cardiomyopathy.
    Kobayashi T; Tadokoro H; Matsumoto K
    Intern Med; 2013; 52(12):1369-73. PubMed ID: 23774549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac pharmacology and cardiomyopathy in Friedreich's ataxia.
    Huxtable RJ
    Can J Neurol Sci; 1978 Feb; 5(1):83-91. PubMed ID: 25706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The varying evolution of Friedreich's ataxia cardiomyopathy.
    Casazza F; Morpurgo M
    Am J Cardiol; 1996 Apr; 77(10):895-8. PubMed ID: 8623752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyopathy in Friedreich's ataxia.
    Rahman F; Pandolfo M
    Acta Neurol Belg; 2011 Sep; 111(3):183-7. PubMed ID: 22141280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress.
    Das SK; Patel VB; Basu R; Wang W; DesAulniers J; Kassiri Z; Oudit GY
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28115312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional mouse models for Friedreich ataxia, a neurodegenerative disorder associating cardiomyopathy.
    Puccio H
    Handb Exp Pharmacol; 2007; (178):365-75. PubMed ID: 17203663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.